PharmChem Gross Margin 2023-2024 | PCHM

Current and historical gross margin for PharmChem (PCHM) over the last 10 years. The current gross profit margin for PharmChem as of December 31, 2024 is %.
PharmChem Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-12-31 $0.01B $0.01B 100.00%
2024-09-30 $0.01B $0.01B 100.00%
2024-06-30 $0.01B $0.01B 100.00%
2024-03-31 $0.01B $0.01B 100.00%
2023-12-31 $0.01B $0.01B 100.00%
2023-09-30 $0.01B $0.01B 100.00%
2023-06-30 $0.01B $0.01B 100.00%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.014B $0.006B
PharmChem is an independent laboratory providing integrated drug testing services on a national basis to corporate and governmental clients seeking to detect and deter the use of illegal drugs. PharmChem operates a certified forensic drug-testing laboratory in Haltom City, Texas.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.755B 19.47
Encompass Health (EHC) United States $11.734B 24.87
DaVita (DVA) United States $11.050B 14.67
Chemed (CHE) United States $8.342B 26.22
Elanco Animal Health (ELAN) United States $5.940B 12.72
Option Care Health (OPCH) United States $5.214B 23.24
RadNet (RDNT) United States $4.181B 88.48
Amedisys (AMED) United States $3.128B 21.04
LifeStance Health (LFST) United States $2.228B 0.00
Addus HomeCare (ADUS) United States $2.041B 22.41
Astrana Health (ASTH) United States $1.666B 41.26
U.S Physical Therapy (USPH) United States $1.125B 29.05
Aveanna Healthcare Holdings (AVAH) United States $1.054B 60.00
Pennant (PNTG) United States $0.985B 36.18
Atai Life Sciences (ATAI) Germany $0.278B 0.00
Daxor (DXR) United States $0.037B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
Psychemedics (PMD) United States $0.000B 0.00